Antipodes Partners’s Palantir PLTR Stock Holding History

Antipodes Partners’s Portfolio PLTR Stock Details PLTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,330,879	Closed	-$51.1M	–	77
2023 Q2	$51.1M	Buy	+3,330,879	New	+$37.9M	1.76%	25

Other funds holding PLTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Antipodes Partners's PLTR Position: Q3 2023 in Review

Antipodes Partners sold out of Palantir (PLTR) in Q3 2023, closing a stake of 3,330,879 shares — an estimated $51.1M sold.

Antipodes Partners first reported a position in PLTR in Q2 2023 and held it in 1 quarter. The position peaked at $51.1M in Q2 2023. 913 funds tracked by Wall St. Rank hold PLTR as of Q3 2023.

Antipodes Partners reported no remaining Palantir position as of Q3 2023 after selling out during the quarter.
Antipodes Partners sold 3,330,879 Palantir shares in Q3 2023, an estimated $51.1M.
Antipodes Partners first reported a position in Palantir in Q2 2023 and held it in 1 quarter.
Antipodes Partners's Palantir position peaked at $51.1M in Q2 2023.
913 funds tracked by Wall St. Rank held Palantir as of Q3 2023.

Based on Antipodes Partners's 13F filing for Q3 2023, filed 13 Nov 2023.